Cardiology is the study of diseases and abnormalities of the heart and cardiovascular tissue, playing an integral role in many intersecting fields of medicine. With 1 in every 4, cardiovascular disease is the leading cause of death for both men and women in the U.S. (CDC)

Cardio-Endo-Renal Collaborative (CERC) Clinical Connections™
Advancements in novel therapies and technologies, lifestyle medicine, multidisciplinary approaches that are driving improvements in outcomes and quality, and cardiovascular (CVD)/metabolic disease prevention.
CME: 2.0
Clinical Practice Connections™: New York Advanced Practice Collaborative
Summary of guideline updates, clinical expertise, and new or emerging treatments for major chronic illnesses encountered daily in family practice medicine.
CME: 1.25
The Role of Non-Statin Therapies for LDL-C Lowering for Management of ASCVD Risk
Provide insight on statin intolerance and discuss nonstatin treatment options as well as compare and contrast indications for the PCSK9 inhibitors.
CME: 1.0
Medical Crossfire®: Optimal Lipid Management for Primary Care Practitioners: An Update on PCSK9 Inhibitors
Engage in a multidisciplinary roundtable discussion to discuss how to best optimize and individualize hypercholesterolemia management with newer therapies.
CME: 1.5
How and When to Consider a PCSK9 Inhibitor in Practice
Review the latest clinical trial data on PCSK9 inhibitors in reducing cardiovascular events in patients with hypercholesterolemia.
CME: 0.5
Getting to the Heart of Type 2 Diabetes Management: Practice Insights for Nurse Practitioners and Physician Assistants
Using a case-based approach, apply CVOT data and current guideline recommendations to individualize glucose lowering therapy and reduce cardiovascular risk in patients with T2D.
CME: 1.0
Can We Do It Better: Improving Outcomes in Patients with Atrial Fibrillation
Select appropriate AF patients for rate, rhythm, or ablation therapy in accordance with current guideline recommendations to optimize outcomes.
CME: 0.5
A Virtual Reality Tour of Nonstatin LDL-C-lowering Agents that Decrease Cardiovascular Risk for Patients with Persistent Hypercholesterolemia
Discuss the latest clinical trial data available on nonstatin LDL-C–lowering agents and their position in treatment regimens for patients with elevated LDL-C levels
CME: 1.0